Loading…
Reported covered position: Senate Finance Committee
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Medicare Access and CHIP Reauthorization Act of 2015
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Nuclear medicine reimbursement generally and nuclear medicine APC's under HOPPS and appropriate use criteria under the MPFS specifically. Sustainable growth rate provisions of H.R. 2, the "Medicare Access and CHIP Reauthorization Act of 2015."
Medicare Access and CHIP Reauthorization Act of 2015
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2015 · second_quarter · Q2
Domestic isotope supply issues generally, including oversight of the American Medical Isotope Production Act of 2011. Medical radiation issues generally, including Nuclear Regulatory Commission regulations.
Nuclear medicine reimbursement generally and nuclear medicine APC's under HOPPS and appropriate use criteria under the MPFS specifically. Sustainable growth rate provisions of H.R. 2, the "Medicare Access and CHIP Reauthorization Act of 2015."
Filing targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), Office of Science & Technology Policy (OSTP), SENATE
Source: Senate LDA
Nuclear medicine reimbursement generally and nuclear medicine APC's under HOPPS specifically. Sustainable growth rate provisions of H.R. 2, the "Medicare Access and CHIP Reauthorization Act of 2015."
Drug Quality and Security Act
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Pharmacy compounding of radiopharmaceuticals; The Drug Quality and Security Act (HR 3204).
Protecting Access to Medicare Act of 2014
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Nuclear medicine reimbursement generally and under HOPPS and MPFS specifically. Imaging provisions of physician payment reform legislation amending the sustainable growth rate (H.R. 4302, the Protecting Access to Medicare Act of 2014)
Protecting Access to Medicare Act of 2014
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Nuclear medicine reimbursement generally and under HOPPS and MPFS specifically. Imaging provisions of physician payment reform legislation amending the sustainable growth rate (HR 4302, the Protecting Access to Medicare Act of 2014).
Protecting Access to Medicare Act of 2014
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Nuclear medicine reimbursement generally and under HOPPS and MPFS specifically. Imaging provisions of physician payment reform legislation amending the sustainable growth rate (H.R. 4302, the Protecting Access to Medicare Act of 2014).
Protecting Access to Medicare Act of 2014
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Nuclear medicine reimbursement generally and under HOPPS and MPFS specifically. Imaging provisions of physician payment reform legislation amending the sustainable growth rate (H.R. 4302, the Protecting Access to Medicare Act of 2014).
Establishing the budget for the United States Government for fiscal year 2014 and setting forth appropriate budgetary levels for fiscal years 2015 through 2023.
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
FY'13 (H.R. 5325; S. 2465; and H.R. 933, Consolidated and Further Continuing Appropriations Act, 2013), regarding Energy/Water Appropriations for Department of Energy funding opportunities for nuclear medicine research. FY '14 Energy/Water appropriations regarding DOE funding opportunities for nuclear medicine research. S. Con. Res. 8 and H. Con. Res. 25 regarding health care policy, generally. FY '14 Labor/HHS appropriations regarding NIBIB funding opportunities for nuclear medicine research
Drug Quality and Security Act
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Pharmacy compounding of radiopharmaceuticals; The Drug Quality and Security Act (H.R. 3204).
Drug Quality and Security Act
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Pharmacy compounding of radiopharmaceuticals; The Drug Quality and Security Act (HR 3204).
American Manufacturing Workforce Act of 2014
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
FY'13 (H.R. 5325; S. 2465; and H.R. 933, Consolidated and Further Continuing Appropriations Act, 2013), regarding Energy/Water Appropriations for Department of Energy funding opportunities for nuclear medicine research. FY '14 Energy/Water appropriations regarding DOE funding opportunities for nuclear medicine research. S. Con. Res. 8 and H. Con. Res. 25 regarding health care policy, generally. FY '14 Labor/HHS appropriations regarding NIBIB funding opportunities for nuclear medicine research
Energy and Water Development and Related Agencies Appropriations Act, 2014
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
FY '14 (S. 1245, and HR 2609) Energy/Water Appropriations regarding Department of Energy funding opportunities for nuclear medicine research (Title III) FY '14 Labor/HHS/Education appropriations regarding National Institute of Biomedical Imaging and Bioengineering funding opportunities for nuclear medicine research.
Energy and Water Development and Related Agencies Appropriations Act, 2014
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
FY '14 (S. 1245, and House bill) Energy/Water Appropriations regarding Department of Energy funding opportunities for nuclear medicine research (Title III) FY'14 Labor/HHS/Education appropriations regarding National Institute of Biomedical Imaging and Bioengineering funding opportunities for nuclear medicine research.
Energy and Water Development and Related Agencies Appropriations Act, 2014
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
FY '14 (S. 1245, and HR 2609) Energy/Water Appropriations regarding Department of Energy funding opportunities for nuclear medicine research (Title III) FY '14 Labor/HHS/Education appropriations regarding National Institute of Biomedical Imaging and Bioengineering funding opportunities for nuclear medicine research.
Albuquerque Indian School Land Transfer Act
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
FY'13 (H.R. 5325; S. 2465; and H.R. 933, Consolidated and Further Continuing Appropriations Act, 2013), regarding Energy/Water Appropriations for Department of Energy funding opportunities for nuclear medicine research. FY '14 Energy/Water appropriations regarding DOE funding opportunities for nuclear medicine research. S. Con. Res. 8 and H. Con. Res. 25 regarding health care policy, generally. FY '14 Labor/HHS appropriations regarding NIBIB funding opportunities for nuclear medicine research
Pharmaceutical Quality, Security, and Accountability Act
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Pharmacy compounding of radiopharmaceuticals; S. 959, Pharmaceutical Quality, Security, and Accountability Act), nuclear medicine provisions.
American Sovereignty Restoration Act of 2009
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2011 (H.R. 1146 and S. 642); implementation of the Affordable Care Act generally.
American Sovereignty Restoration Act of 2009
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2011 (HR 1146 and S 642); implementation of the Affordable Care Act generally.
American Sovereignty Restoration Act of 2009
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Implementation of the Affordable Care Act generally. Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2011 (H.R. 1146 and S. 642)
American Sovereignty Restoration Act of 2009
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2011 (H.R. 1146 and S. 642) Implementation of the Affordable Care Act generally.
American Taxpayer Relief Act of 2012
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Nuclear medicine reimbursement generally and under HOPPS and MPFS specifically. Sustainable growth rate (SGR) physician payment reform generally. H.R. 8 (American Taxpayer Relief Act of 2012).
Proposing an amendment to the Constitution of the United States to protect the rights of crime victims.
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Nuclear medicine reimbursement generally and under HOPS and MPFS specifically. Imaging provisions of physician payment reform legislation amending the sustainable growth rate (HJ Res 59).
A concurrent resolution expressing support for Children's Dental Health Month and honoring the memory of Deamonte Driver.
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
FY'13 (H.R. 5325; S. 2465; and H.R. 933, Consolidated and Further Continuing Appropriations Act, 2013), regarding Energy/Water Appropriations for Department of Energy funding opportunities for nuclear medicine research. FY '14 Energy/Water appropriations regarding DOE funding opportunities for nuclear medicine research. S. Con. Res. 8 and H. Con. Res. 25 regarding health care policy, generally. FY '14 Labor/HHS appropriations regarding NIBIB funding opportunities for nuclear medicine research
Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Implementation of the Affordable Care Act generally Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011 (H.R. 2104 and S. 3338) Comparative Effectiveness Research (CER) generally
Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Implementation of the Affordable Care Act generally Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011 (H.R. 2104 and S. 3338) Comparative Effectiveness Research (CER) generally
Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Implementation of the Affordable Care Act generally Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011 (H.R. 2104) Comparative Effectiveness Research (CER) generally
Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Implementation of the Affordable Care Act generally Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2011 (H.R. 2104 and S. 3338) Comparative Effectiveness Research (CER) generally
Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Implementation of Affordable Care Act generally Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011 (H.R. 2104) Comparative Effectiveness Research (CER) generally
Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Implementation of the Affordable Care Act generally Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011 (H.R. 2104) Comparative Effectiveness Research (CER) generally
Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011
Client: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING · Firm: SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Implementation of the Affordable Care Act generally Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011 (H.R. 2104) Comparative Effectiveness Research (CER) generally
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2015 · first_quarter · Q1
Nuclear medicine reimbursement generally and nuclear medicine APC's under HOPPS specifically. Sustainable growth rate provisions of H.R. 2, the "Medicare Access and CHIP Reauthorization Act of 2015."
Energy/Water and Labor/HHS/Education appropriations generally for DOE and NIH funding opportunities for nuclear medicine.
Domestic isotope supply issues generally, including oversight of the American Medical Isotope Production Act of 2011. Medical radiation issues generally, including Nuclear Regulatory Commission regulations.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), Office of Science & Technology Policy (OSTP), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2014 · fourth_quarter · Q4
Domestic isotope supply issues, including oversight of the American Medical Isotope Production Act of 2011. Medical radiation issues generally, including Nuclear Regulatory Commission regulations.
Nuclear medicine reimbursement generally and under HOPPS and MPFS specifically. Imaging provisions of physician payment reform legislation amending the sustainable growth rate (HR 4302, the Protecting Access to Medicare Act of 2014).
FY15 Energy/Water Appropriations (HR 83, FY2015 Omnibus Appropriations bill) regarding the DOE funding opportunities for nuclear medicine research. Funding for the National Nuclear Chemistry Summer Schools. FY15 Labor/HHS/Education appropriations regarding National Institute of Biomedical Imaging and Bioengineering funding opportunities for nuclear medicine research.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), Office of Science & Technology Policy (OSTP), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2014 · third_quarter · Q3
Domestic isotope supply issues, including oversight of the American Medical Isotopes Production Act of 2011. Medical radiation issues generally, including Nuclear Regulatory Commission regulations.
Nuclear medicine reimbursement generally and under HOPPS and MPFS specifically. Imaging provisions of physician payment reform legislation amending the sustainable growth rate (H.R. 4302, the Protecting Access to Medicare Act of 2014).
FY'15 Energy/Water Appropriations (HR 3547, the Consolidated Appropriations Act) regarding DOE funding opportunities for nuclear medicine research. Funding for the National Nuclear Chemistry Summer School. FY'15 Labor/HHS/Education appropriations regarding National Institute of Biomedical Imaging and Bioengineering funding opportunities for nuclear medicine research.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), Office of Science & Technology Policy (OSTP), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2014 · second_quarter · Q2
Domestic isotope supply issues, including oversight of the American Medical Isotopes Production Act of 2011. Medical radiation issues generally, including Nuclear Regulatory Commission regulations.
FY'15 Energy/Water Appropriations (HR 3547, the Consolidated Appropriations Act) regarding Department of Energy funding opportunities for nuclear medicine research. Funding for the National Nuclear Chemistry Summer School. FY'15 Labor/HHS/Education appropriations regarding National Institute of Biomedical Imaging and Bioengineering funding opportunities for nuclear medicine research.
Nuclear medicine reimbursement generally and under HOPPS and MPFS specifically. Imaging provisions of physician payment reform legislation amending the sustainable growth rate (H.R. 4302, the Protecting Access to Medicare Act of 2014).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), Office of Science & Technology Policy (OSTP), SENATE
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2014 · first_quarter · Q1
Domestic isotope supply issues, including oversight of the American Medical Isotopes Production Act of 2011. Medical radiation issues generally, including Nuclear Regulatory Commission regulations.
FY'15 Energy/Water Appropriations (H.R.3547, the Consolidated Appropriations Act) regarding Department of Energy funding opportunities for nuclear medicine research. FY'15 Labor/HHS/Education appropriations regarding National Institute of Biomedical Imaging and Bioengineering funding opportunities for nuclear medicine research.
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2013 · fourth_quarter · Q4
Pharmacy compounding of radiopharmaceuticals; The Drug Quality and Security Act (HR 3204).
FY '14 (S. 1245, and HR 2609) Energy/Water Appropriations regarding Department of Energy funding opportunities for nuclear medicine research (Title III) FY '14 Labor/HHS/Education appropriations regarding National Institute of Biomedical Imaging and Bioengineering funding opportunities for nuclear medicine research.
Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2011 (HR 1146 and S 642); implementation of the Affordable Care Act generally.
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2013 · third_quarter · Q3
Pharmacy compounding of radiopharmaceuticals; The Drug Quality and Security Act (H.R. 3204).
Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2011 (H.R. 1146 and S. 642); implementation of the Affordable Care Act generally.
Domestic isotope supply issues, including the American Medical Isotopes Production Act of 2011. Medical radiation issues generally, including Nuclear Regulatory Commission regulations.
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2013 · second_quarter · Q2
Domestic isotope supply issues, including S. 99 (American Medical Isotopes Production Act of 2011. Medical radiation issues generally, including Nuclear Regulatory Commission regulations.
FY '14 (S. 1245, and House bill) Energy/Water Appropriations regarding Department of Energy funding opportunities for nuclear medicine research (Title III) FY'14 Labor/HHS/Education appropriations regarding National Institute of Biomedical Imaging and Bioengineering funding opportunities for nuclear medicine research.
Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2011 (H.R. 1146 and S. 642) Implementation of the Affordable Care Act generally.
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2013 · first_quarter · Q1
Domestic isotope supply issues, including S. 99 (American Medical Isotopes Production Act of 2011). Medical radiation issues generally, including Nuclear Regulatory Commission regulations.
Nuclear medicine reimbursement generally and under HOPPS and MPFS specifically. Sustainable growth rate (SGR) physician payment reform generally. H.R. 8 (American Taxpayer Relief Act of 2012).
FY'13 (H.R. 5325; S. 2465; and H.R. 933, Consolidated and Further Continuing Appropriations Act, 2013), regarding Energy/Water Appropriations for Department of Energy funding opportunities for nuclear medicine research. FY '14 Energy/Water appropriations regarding DOE funding opportunities for nuclear medicine research. S. Con. Res. 8 and H. Con. Res. 25 regarding health care policy, generally. FY '14 Labor/HHS appropriations regarding NIBIB funding opportunities for nuclear medicine research
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2012 · fourth_quarter · Q4
FY '13 (H.R. 5325; S. 2465) Energy/Water Appropriations regarding Department of Energy funding for nuclear medicine research
Domestic isotope supply issues, including the American Medical Isotopes Production Act of 2011 (S. 99) Medical radiation issues generally, including Nuclear Regulatory Commission regulations
Implementation of the Affordable Care Act generally Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2011 (H.R. 2104 and S. 3338) Comparative Effectiveness Research (CER) generally
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2012 · third_quarter · Q3
Nuclear medicine reimbursement issues generally Sustainable Growth Rate (SGR) physician payment reform issues generally
Domestic isotope supply issues, including the American Medical Isotopes Production Act of 2011 (S. 99) Medical radiation issues generally, including Nuclear Regulatory Commission regulations
FY '12 Department of Energy funding opportunities regarding nuclear medicine research FY '13 (H.R. 5325; S. 2465) Energy/Water Appropriations regarding Department of Energy funding for nuclear medicine research
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2012 · second_quarter · Q2
Domestic isotope supply issues, including the American Medical Isotopes Production Act of 2011 (S. 99) Medical radiation issues generally, including Nuclear Regulatory Commission regulations
Nuclear medicine reimbursement issues generally Sustainable Growth Rate (SGR) physician payment reform issues generally
FY '12 Department of Energy funding opportunities regarding nuclear medicine research FY '13 (H.R. 5325; S. 2465) Energy/Water Appropriations regarding Department of Energy funding for nuclear medicine research
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2012 · third_quarter · RA
Research Funding, isotope production and supply, medical radiation, NRC, FDA and CMS issues impacting medical imaging generally, Medicare reimbursement.
Research Funding, isotope production and supply, medical radiation, NRC, FDA and CMS issues impacting medical imaging generally, Medicare reimbursement.
Research Funding, isotope production and supply, medical radiation, NRC, FDA and CMS issues impacting medical imaging generally, Medicare reimbursement.
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2012 · first_quarter · Q1
FY '12 and FY '13 Department of Energy funding opportunities regarding nuclear medicine research
Nuclear medicine reimbursement issues generally Sustainable Growth Rate (SGR) physician payment reform issues generally
Domestic isotope supply issues, including the American Medical Isotopes Production Act of 2011 (S. 99) Medical radiation issues, including Nuclear Regulatory Commission Part 35 and Part 20 regulations
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2011 · fourth_quarter · Q4
FY '12 (H.R. 2354 and Senate bill (Title III), and Consolidated Appropriations Act, 2012) regarding Department of Energy nuclear medicine basic research funding opportunities
Nuclear medicine reimbursement issue generally Sustainable Growth Rate (SGR) physician payment reform issues generally
Implementation of the Affordable Care Act generally Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011 (H.R. 2104) Comparative Effectiveness Research (CER) generally
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2011 · third_quarter · Q3
FY'11 and FY '12 (HR 2354) Department of Energy nuclear medicine basic research funding opportunities
Domestic isotope supply issues, including the American Medical Isotopes Production Act of 2011 (S. 99) Medical radiation issues, including Nuclear Regulatory Commission Part 35 and Part 20 regulations
Implementation of the Affordable Care Act generally Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011 (H.R. 2104) Comparative Effectiveness Research (CER) generally
SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING via SOCIETY OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
2011 · second_quarter · Q2
Domestic isotope supply issues, including the American Medical Isotopes Production Act of 2011 (S. 99) Medical radiation issues, including Nuclear Regulatory Commission regulations
Implementation of Affordable Care Act generally Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011 (H.R. 2104) Comparative Effectiveness Research (CER) generally
FY '11 and FY '12 (H.R. 2354) Department of Energy nuclear medicine basic research funding opportunities
Nuclear medicine reimbursement generally and under HOPPS and MPFS specifically. Imaging provisions of physician payment reform legislation amending the sustainable growth rate (H.R. 4302, the Protecting Access to Medicare Act of 2014)
Pharmacy compounding of radiopharmaceuticals; The Drug Quality and Security Act (HR 3204).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Science & Technology Policy (OSTP), SENATE
Domestic isotope supply issues, including the American Medical Isotopes Production Act of 2011. Medical radiation issues generally, including Nuclear Regulatory Commission regulations.
Nuclear medicine reimbursement generally and under HOPS and MPFS specifically. Imaging provisions of physician payment reform legislation amending the sustainable growth rate (HJ Res 59).
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
Nuclear medicine reimbursement generally and under HOPPS and MPFS specifically. Sustainable growth rate (SGR) physician payment reform generally.
FY '14 (S. 1245, and HR 2609) Energy/Water Appropriations regarding Department of Energy funding opportunities for nuclear medicine research (Title III) FY '14 Labor/HHS/Education appropriations regarding National Institute of Biomedical Imaging and Bioengineering funding opportunities for nuclear medicine research.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
Pharmacy compounding of radiopharmaceuticals; S. 959, Pharmaceutical Quality, Security, and Accountability Act), nuclear medicine provisions.
Nuclear medicine reimbursement generally and under HOPPS and MPFS specifically. Sustainable growth rate (SGR) physician payment reform generally.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Nuclear Regulatory Commission (NRC), SENATE
Implementation of the Affordable Care Act generally. Consistency, Accuracy, Responsibility and Excellence in Medical Imaging and Radiation Therapy Act of 2011 (H.R. 1146 and S. 642)
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, Food & Drug Administration (FDA), Natl Institutes of Health (NIH)
Nuclear medicine reimbursement issues generally Sustainable Growth Rate (SGR) physician payment reform issues generally
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Implementation of the Affordable Care Act generally Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011 (H.R. 2104 and S. 3338) Comparative Effectiveness Research (CER) generally
Filing targets: Centers For Medicare and Medicaid Services (CMS), Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
Implementation of the Affordable Care Act generally Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011 (H.R. 2104 and S. 3338) Comparative Effectiveness Research (CER) generally
Filing targets: Energy, Dept of, HOUSE OF REPRESENTATIVES, SENATE
Research Funding, isotope production and supply, medical radiation, NRC, FDA and CMS issues impacting medical imaging generally, Medicare reimbursement.
Implementation of the Affordable Care Act generally Consistency, Accuracy, Responsibility, and Excellence in Medical Imaging and Radiation Therapy Act of 2011 (H.R. 2104) Comparative Effectiveness Research (CER) generally
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
Domestic isotope supply issues, including the American Medical Isotopes Production Act of 2011 (S. 99) Medical radiation issues, including Nuclear Regulatory Commission Part 35 and Part 20 regulations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Nuclear medicine reimbursement issues generally
Filing targets: HOUSE OF REPRESENTATIVES, Nuclear Regulatory Commission (NRC), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE